Pain Control in Latin America: The Optimized Role of Buprenorphine in the Treatment of Cancer and Noncancer Pain
- PMID: 31102146
- PMCID: PMC6857113
- DOI: 10.1007/s40122-019-0126-0
Pain Control in Latin America: The Optimized Role of Buprenorphine in the Treatment of Cancer and Noncancer Pain
Abstract
Pain is a terrible health problem that transcends borders and nationalities, although there may be significant differences among regions regarding pain management. In Latin America (LatAm, composed of the many nations of Central America, South America, Mexico, and the Caribbean), access to healthcare, pain management, and opioid analgesics can vary. Despite an international U.S.-led trend toward greater control in opioid prescribing, the role of opioids in the management of severe pain in LatAm is probably smaller than it should be, as opioid consumption in LatAm overall is low. Buprenorphine is a strong opioidwith certain characteristics that make it a potentially useful analgesic agent in LatAm: it has a unique pharmacology that allows for transdermal administration and a favorable safety profile with a ceiling effect for respiratory depression. It has a well-studied low risk potential for misuse, and there is strong evidence for its safety and efficacy in managing both cancer and noncancer pain in adults. Caregivers and policy makers in LatAm may learn from the U.S. experience with opioids in order to develop protocols to better and safely manage pain, and it is possible that buprenorphine will play a key role.
Keywords: Latin America; Opioid; Opioid use in Latin America; Pain control.
Conflict of interest statement
Joseph V. Pergolizzi, Jr. is a member of the journal's Editorial Board. Robert Taylor, Jr., Jo Ann LeQuang, Argelia Lara, Andres Hernandez Ortiz and Miguel A. Ruiz Iban have nothing to disclose.
Similar articles
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain.J Pain Res. 2015 Dec 4;8:859-70. doi: 10.2147/JPR.S85951. eCollection 2015. J Pain Res. 2015. PMID: 26672499 Free PMC article. Review.
-
Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Latin America and the Caribbean: a report from the Global Opioid Policy Initiative (GOPI).Ann Oncol. 2013 Dec;24 Suppl 11:xi41-50. doi: 10.1093/annonc/mdt502. Ann Oncol. 2013. PMID: 24285228
-
Transdermal buprenorphine for moderate chronic noncancer pain syndromes.Expert Rev Neurother. 2018 May;18(5):359-369. doi: 10.1080/14737175.2018.1462701. Epub 2018 Apr 23. Expert Rev Neurother. 2018. PMID: 29667437
-
The unique role of transdermal buprenorphine in the global chronic pain epidemic.Acta Anaesthesiol Taiwan. 2015 Jun;53(2):71-6. doi: 10.1016/j.aat.2015.06.001. Epub 2015 Jul 21. Acta Anaesthesiol Taiwan. 2015. PMID: 26205326
Cited by
-
Buprenorphine for Chronic Pain: A Safer Alternative to Traditional Opioids.Health Psychol Res. 2021 Aug 6;9(1):27241. doi: 10.52965/001c.27241. eCollection 2021. Health Psychol Res. 2021. PMID: 34746493 Free PMC article. Review.
References
-
- World Bank. News: Universal healthcare on the rise in Latin America. 2013. http://www.worldbank.org/en/news/feature/2013/02/14/universal-healthcare.... Accessed Dec 20, 2018.
Publication types
LinkOut - more resources
Full Text Sources